Earlham Institute (EI) add Illumina’s NovaSeq 6000 to its National Capability in Genomics and Single Cell Analysis, harnessing the power of ultra-high throughput sequencing for Norwich Research Park and the wider bioscience community. The new platform will increase its sequencing capacity threefold and enable big data science more rapidly and cost-effectively than ever before, with […]
ST. LOUIS–PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that TriCore Reference Laboratories will utilize the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for genomic analytics, classification, interpretation and reporting. TriCore will join more than 50 other customers who benefit from shared interpretations in the PierianDx KnowledgeSpace, a […]
Genovis continues to expand in Asia and has signed a distribution agreement with Chayon Laboratories Inc. for the South Korean market. The agreement covers sales from Genovis’ current and future products. It was a South Korean company that had the world’s first antibody-biosimilar approved. Since then, the market for biopharmaceuticals has continued to grow strongly […]
New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results (ANN ARBOR, Mich.) Swift Biosciences today announced the launch of its Accel-NGS® Unique Dual Indexing Kits, which deliver the power and value of high-throughput multiplexed sequencing while improving the accuracy of low frequency variant calling, such as somatic mutations, in samples such as FFPE and cfDNA. […]
–CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes– PLEASANTON, CA.—10x Genomics, a company focused on accelerating genomic discovery, announced today a partnership with the CanSeq150 Initiative, a sequencing initiative by Canada’s Genomics Enterprise (CGEn). CanSeq150 aims to sequence 150 new genomes to support […]
DANVERS, MA. Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has opened a new office in Shanghai China to support the rapidly expanding China life science market and the growth of the CST business in the country. The new facility triples the office and warehouse footprint and will feature CST’s Global […]
DANVERS, MA — Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has opened a new office in Shanghai China to support the rapidly expanding China life science market and the growth of the CST business in the country. The new facility triples the office and warehouse footprint and will feature CST’s […]
Dundee, UK: Ubiquigent Limited announced today that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. Under the terms of the collaboration agreement, Ubiquigent will receive an upfront payment with research support and is eligible for possible additional milestones payments. […]
Collaboration will support translational research that demonstrates the value of PGx in precision medicine PITTSBURGH — Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines expertise and technology in genomics, bioinformatics, implementation science, medication response phenotyping and education. The Center aims to discover and validate medication response predictors in […]
WALTHAM, Massachusetts – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program. Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in childhood, affecting approximately 1 in every 5,000 live male births (about 20,000 new […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
